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Epidermal FABP (FABP5) Regulates Keratinocyte
Differentiation by 13(S)-HODE-Mediated Activation
of the NF-jB Signaling Pathway
Eisaku Ogawa1,2,9, Yuji Owada3,9, Shuntaro Ikawa4, Yasuhiro Adachi3, Teie Egawa2, Kei Nemoto3,5,
Kaori Suzuki6, Takanori Hishinuma6, Hiroshi Kawashima7, Hisatake Kondo8, Masahiko Muto5, Setsuya Aiba2
and Ryuhei Okuyama1
Fatty acid-binding proteins (FABPs) are postulated to serve as lipid shuttles that solubilize hydrophobic fatty
acids and deliver them to appropriate intracellular sites. Epidermal FABP (E-FABP/FABP5) is predominantly
expressed in keratinocytes and is overexpressed in the actively proliferating tissue characteristic of psoriasis
and wound healing. In this study, we found decreased expression of the differentiation-specific proteins keratin 1,
involucrin, and loricrin in E-FABP/ keratinocytes relative to E-FABPþ /þ keratinocytes. We also determined that
incorporation of linoleic acid was significantly reduced in E-FABP/ keratinocytes. Although linoleic acid did
not directly affect keratinocyte differentiation, keratin 1 expression was induced by the linoleic acid derivative
13(S)-hydroxyoctadecadienoic acid (13(S)-HODE), and this induction was concomitant with increased NF-kB
activity. In E-FABP/ keratinocytes, the expression of 13(S)-HODE and the subsequent induction of NF-kB
activity was lower than in wild-type keratinocytes. The reduction of linoleic acid in E-FABP/ keratinocytes led
to decreased cellular 13(S)-HODE content, resulting in decreased keratin 1 expression through downregulation
of NF-kB activity. The regulation of fatty acid metabolism by E-FABP during keratinocyte differentiation suggests
that E-FABP may have a role in the pathogenesis of psoriasis.
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INTRODUCTION
Fatty acids serve as both an energy source and as membrane
structural components. They are especially rich in the stratum
corneum of the epidermis and form the structure of the
intercellular lipid matrix. Special attention has been given to
the relationship between fatty acids and psoriasis vulgaris, a
skin disease characterized by epidermal hyperproliferation and
altered epidermal differentiation. It has been reported that a
high intake of dietary fat is positively correlated with the
occurrence of psoriasis vulgaris (Zamboni et al., 1989), and that
consumption of dietary fish oil and n-3 fatty acids can improve
symptoms of psoriasis (Kragballe and Fogh, 1989; Mayser et al.,
2002). These lines of evidence support an association between
skin homeostasis and fatty acid metabolism.
Long-chain fatty acids are virtually insoluble in aqueous
environments because of their hydrophobic nature. Fatty
acids rely on specific processes for efficient transport into
cells and intracellular movement. Fatty acid-binding proteins
(FABPs), which are believed to have a role in these processes,
are capable of binding long-chain fatty acids, and comprise
a family of cytosolic proteins consisting of 410 isoforms
(Coe and Bernlohr, 1998). Among these, epidermal FABP
(E-FABP), also known as FABP5 or mal1, was first isolated
from the epidermis, and is expressed in tissues throughout the
body, including the brain and liver (Hotamisligil et al., 1996;
Owada et al., 1996; Masouye et al., 1997). As E-FABP is
expressed abundantly in the epidermis, it has been proposed
to act as a cellular lipid chaperone in keratinocyte homeo-
stasis (Siegenthaler et al., 1993; Owada et al., 1996;
O’Shaughnessy et al., 2000).
The epidermis is a rapidly renewing tissue composed of a
basal layer, spinous layers, granular layers, and cornified
layers. Basal keratinocytes are immature cells that proliferate
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continuously. During the early stages of differentiation,
keratinocytes begin to migrate into the upper layers, cease
proliferating, and begin to express differentiation-specific
proteins, including keratin 1 (K1) and K10. During differ-
entiation, involucrin (Inv) and loricrin (Lor) are expressed in
the uppermost layers (reviewed in Dotto (1999); Fuchs
(2008)). As E-FABP expression is upregulated in the psoriatic
epidermis, it is believed to have a role in keratinocyte
regulation (Zhu et al., 1999). It has been speculated that
E-FABP expression is increased in response to increased lipid
traffic, which may be related to abnormal keratinocyte
proliferation and differentiation in psoriasis. It has been
reported that E-FABP induces keratinocyte differentiation by
enhancing the transcriptional activity of peroxisome prolif-
erator-activated receptors (PPARs) by transporting fatty acids
directly to PPARs (Tan et al., 2002). We have previously
demonstrated that the skin of E-FABP/mice appears normal
at the gross and histological levels, but the water-barrier
function of the epidermis is altered in these mice (Owada
et al., 2002). Furthermore, E-FABP deletion results in
impaired keratinocyte migration, suggesting a connection
between E-FABP and cell mobility (Kusakari et al., 2006).
However, the precise function of E-FABP remains elusive. To
clarify the mechanism of E-FABP action in the epidermis, we
analyzed E-FABP/ keratinocytes.
RESULTS
Keratinocytes predominately express E-FABP out of the FABP
protein family
The characteristics of cultured keratinocytes can be modu-
lated by changes in the extracellular calcium concentration.
When cultured in a low-calcium medium, keratinocytes
mimic undifferentiated proliferating cells (Hennings et al.,
1980), whereas in a high-calcium medium (2mM), cells
differentiate relatively rapidly (Missero et al., 1996). We
measured the expression of E-FABP and other FABPs in
keratinocytes and found that E-FABP expression, which was
detectable even in undifferentiated keratinocytes, gradually
increased as differentiation progressed (Figure 1a). This
observation was consistent with our in vivo findings, in
which E-FABP was detectable throughout the epidermis but
was more abundant in differentiated cell layers (Figure 1b). In
previous studies, no FABP isoforms other than E-FABP were
detected in the normal epidermis (Siegenthaler et al., 1993;
Owada et al., 1996; O’Shaughnessy et al., 2000). We used
DNA microarray analysis to monitor the gene expression of
FABP family members in cultured keratinocytes to determine
whether E-FABP deletion was offset by a compensatory
induction of other FABPs. Adipocyte FABP (A-FABP) mRNA
was expressed weakly in E-FABPþ /þ keratinocytes, and its
expression increased B4-fold in E-FABP/ cells (Figure 1c).
The expression of other FABP isoforms was negligible. To
confirm these results, we performed reverse transcriptase-
PCR analysis of brain FABP, heart FABP, and A-FABP, all of
which structurally resemble E-FABP and have similar binding
properties (Hanhoff et al., 2002). A-FABP was increased in
E-FABP/ keratinocytes (Figure 1d), which is consistent with
the results of our DNA microarray analysis. However,
immunoblot analysis demonstrated that A-FABP expression
was weak in both wild-type and E-FABP/ keratinocytes
(Figures 1a and e). Thus, we conclude that keratinocytes
predominately express E-FABP, and that E-FABP deletion is
not offset by the upregulation of other FABPs at the protein
level.
E-FABP deletion affects keratinocyte differentiation but not
proliferation
The effects of E-FABP on growth and differentiation have not
been previously elucidated. We analyzed the role of E-FABP
in cell proliferation by monitoring bromodeoxyuridine
incorporation in cultured keratinocytes. Under low-calcium
conditions, active proliferation of E-FABP/ keratinocytes
was observed, similar to that seen in E-FABPþ /þ cells, and
the addition of the high-calcium medium induced growth
arrest, regardless of E-FABP expression (Figure 2a). Immuno-
histochemical analysis of the cellular proliferation marker
Ki67 revealed that there was no difference in the ratio of
Ki67-positive cells to total basal cells in the E-FABP/ and
E-FABPþ /þ epidermis in vivo (Figure 2b). Thus, the loss of
E-FABP expression does not alter keratinocyte proliferation.
Next, we examined the role of E-FABP in cellular
differentiation. Increased calcium in the culture medium
induced the expression of differentiation-specific proteins,
including K1, Inv, and Lor, in E-FABPþ /þ keratinocytes.
However, in E-FABP/ keratinocytes, this induction was
decreased (Figure 2c). Furthermore, the expression of K1, Inv,
and Lor was also decreased in the E-FABP/ epidermis
relative to the E-FABPþ /þ epidermis (Figure 2d). Taken
together, these results demonstrate that the loss of E-FABP
expression affects keratinocyte differentiation.
Linoleic acid is decreased in the E-FABP/ epidermis
Deletion of E-FABP does not lead to a significant increase in
the expression of A-FABP protein. As E-FABP can have a role
in the regulation of the uptake and storage of fatty acids, we
postulated that E-FABP deletion might disrupt fatty acid
metabolism in keratinocytes. Therefore, we examined the
fatty acid composition of the E-FABP/ epidermis. Gas–
liquid chromatographic analysis showed a decrease in the
total fatty acid content in all fractions of the E-FABP/
epidermis relative to the E-FABPþ /þ epidermis, including
decreased saturated, monounsaturated, and polyunsaturated
fatty acids (Figure 3a). A detailed examination revealed that
several specific fatty acids were decreased in the E-FABP/
epidermis (Supplementary Figure S1 online). Linoleic acid, a
polyunsaturated fatty acid, was significantly decreased in the
E-FABP/ epidermis, whereas arachidonic and linolenic
acid content was unchanged (Figure 3b and Supplementary
Figure S1 online). Measurement of linoleic acid (18C2, n-6)
uptake by cultured keratinocytes confirmed a decrease in
linoleic acid in E-FABP/ cells throughout the time course
(Figure 3c). In contrast, although the uptake of a-linolenic
acid (18C3, n-3) was lower in E-FABP
/ than in E-FABPþ /þ
keratinocytes at 30 and 60minutes after treatment, respec-
tively, no significant difference was observed between the
two groups at 120 or 240minutes, respectively. Collectively,
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these results show that E-FABP deletion results in decreased
fatty acid content, especially of the essential n-6 fatty acid
linoleic acid, in the epidermis.
A linoleic acid derivative, 13-HODE, modulates K1 induction
In contemplating the possible link between decreased
linoleic acid content and impaired keratinocyte differentia-
tion, we considered the possibility that linoleic acid directly
affects the expression of differentiation-specific proteins.
However, because the addition of linoleic acid did not affect
the expression of K1, Inv, or Lor, we concluded that this
possibility was unlikely (Figure 4a). Thus, we examined the
effects of hydroxyoctadecadienoic acids (HODEs), deriva-
tives of linoleic acid synthesized by lipoxygenases (LOXs)
(Kuhn, 1996), on the expression of differentiation-specific
proteins. Mammalian tissues, including the epidermis,
are known to predominantly contain 13(S)-HODE, in
addition to a small amount of 9(S)-HODE (Nugteren and
Kivits, 1987). Among differentiation-specific proteins, K1
expression was enhanced by 13(S)-HODE, but not by 9(S)-
HODE, in wild-type keratinocytes (Figure 4b). In contrast,
neither 13(S)-HODE nor 9(S)-HODE altered the expression of
Inv or Lor. Using liquid chromatography/tandem mass
spectrometry, we established that E-FABP/ keratinocytes
contained lower levels of 13-HODE (Figure 4c), which was in
agreement with our immunohistological staining of 13(S)-
HODE in the E-FABP/ epidermis (Figure 4d). Thus,
downregulation of the K1 expression in E-FABP/ keratino-
cytes may be attributable to a decrease in the linoleic acid
derivative 13(S)-HODE.
Next, we examined the expression of LOXs responsible for
HODE synthesis. Although 15(S)-LOX produces 13(S)-HODE
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Figure 1. FABP expression in keratinocytes. (a) E-FABP was the predominantly expressed isoform. Keratinocytes were cultured in low- or high-calcium medium
for the indicated periods of time. K5 was used as a loading control. (b) Immunohistochemical analysis of E-FABP in the E-FABPþ /þ and E-FABP/ epidermis.
Broken lines indicate the dermal/epidermal junction. Bar¼25 mm. (c) DNA microarray analysis of FABP isoform expression in E-FABPþ /þ and E-FABP/
keratinocytes. Affymetrix IDs are shown. Dotted lines indicate equivalent amounts and 4-fold changes. (d) RT-PCR analysis of FABP isoform expression.
(e) A-FABP protein expression. Keratinocytes were cultivated similarly to those in panel a. Mouse 3T3-L1 embryonic fibroblasts were cultured and induced to
differentiate into adipocytes. Tubulin-a was used as a loading control. Similar results were obtained from three independent experiments. A-FABP, adipocyte
fatty acid-binding protein; E-FABP, epidermal fatty acid-binding protein; FABP, fatty acid-binding protein; RT-PCR, reverse transcriptase-PCR.
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in humans, this protein is not expressed in mice (Heidt et al.,
2000; Furstenberger et al., 2007). The LOX family consists of
seven isoforms, some of which have been reported to
synthesize 13(S)-HODE in mice (Burger et al., 2000).
However, it has not yet been determined which LOXs are
active in keratinocytes. DNA microarray analysis revealed no
differences in LOX expression in E-FABP/ and E-FABPþ /þ
keratinocytes (Figure 4e). Reverse transcriptase-PCR analysis
yielded similar results (Figure 4f). Thus, the decrease in 13(S)-
HODE levels observed in E-FABP/ keratinocytes can likely
be explained by the decrease in linoleic acid, rather than by
changes in LOX expression.
13(S)-HODE induces K1 expression through NF-jB activation
To elucidate the mechanism by which E-FABP regulates
keratinocyte differentiation, we focused on the effects
of 13(S)-HODE in K1 induction. We examined NF-kB
activity, which is altered in E-FABP/ dendritic cells
(Kitanaka et al., 2006). Transactivation of the NF-kB response
element was increased by treatment with 13(S)-HODE,
but not by 9(S)-HODE (Figure 5a). Consistent with this,
13(S)-HODE increased the phosphorylation of IkBa at serine
32, which induces IkB degradation and thereby activates
NF-kB (Figure 5b). 13(S)-HODE also increased the phosphory-
lation of Ik kinase-b at tyrosine 199, which promotes
IkBa phosphorylation and subsequent NF-kB activation
(Figure 5c). Although the NF-kB pathway can be activated
by secreted cytokines, such as tumor necrosis factor-a
and interleukin-1 (DiDonato et al., 1997), we found
that mRNA levels of tumor necrosis factor-a and inter-
leukin-1 were unchanged by the addition of 13(S)-HODE
(Figure 5d).
The 13(S)-HODE-dependent activation of NF-kB suggests
that K1 expression is induced through NF-kB activation.
Indeed, we confirmed that tumor necrosis factor-a, an
NF-kB activator, increased K1 expression in a dose-depen-
dent manner (Figure 5e). We also found that 13(S)-HODE-
dependent K1 induction was abrogated by the NF-kB
inhibitor SN50 (Figure 5f). Taken together, these results
suggest that 13(S)-HODE activates the NF-kB signaling
pathway, leading to K1 induction.
NF-jB activity is decreased in E-FABP/ keratinocytes
The above results suggest that the downregulation of K1 in
E-FABP/ keratinocytes is caused by the suppression of
13(S)-HODE-mediated NF-kB activity. To test this possibility,
we assessed NF-kB activity in E-FABP/ keratinocytes and
found that the NF-kB response element activity was
decreased in E-FABP/ keratinocytes (Figure 6a). In contrast,
AP-1 activity, another signal regulating K1 expression (Huff
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et al., 1993; Lu et al., 1994), did not differ between the two
genotypes. Decreased NF-kB activity in E-FABP/ keratino-
cytes was confirmed by the immunoblotting of phosphory-
lated IkBa (Figure 6b). However, the addition of 13(S)-HODE
to E-FABP/ keratinocytes did not restore NF-kB activation
(Figure 6c), suggesting that E-FABP may be required for
13(S)-HODE-mediated NF-kB activation. In addition, 13(S)-
HODE-dependent K1 induction was markedly reduced in
E-FABP/ keratinocytes (Figure 6d), providing further sup-
port for the idea that E-FABP may be necessary for the
activation of NF-kB.
As 13(S)-HODE has been shown to be a PPAR ligand
(Zuo et al., 2006), we next investigated the impact of E-FABP
deletion on PPAR signaling. However, PPAR activity, as
assessed by a peroxisome proliferator response element
reporter assay, was not different in E-FABP/ and wild-type
keratinocytes (Figure 6e). Furthermore, keratinocytes of both
genotypes had equivalent responses to stimulation by
individual PPAR agonists (Figure 6f), suggesting that E-FABP
has little effect on PPAR signaling in keratinocytes. We also
examined the activation of other signaling pathways, includ-
ing protein kinase C, extracellular signal-regulated kinase,
and p38, but did not detect any significant differences in
activation between the two genotypes (data not shown).
DISCUSSION
The important role of fatty acids in keratinocyte homeostasis
and the observation that E-FABP is the predominantly
expressed FABP in the epidermis provide a rationale to
analyze the phenotype of E-FABP/ keratinocytes. E-FABP
deletion results in decreased cellular linoleic acid and
a subsequent decrease in the linoleic acid derivative
13(S)-HODE. Furthermore, E-FABP seems to have a role in
13(S)-HODE-mediated NF-kB activation, and consequently
in K1 expression. These results suggest a connection between
fatty acid metabolism and signal-mediated keratinocyte
differentiation.
E-FABP deletion leads to decreased linoleic acid
Although the FABP family of proteins is abundantly expressed
in numerous tissues, the individual physiological function of
each isoform is difficult to define because multiple isoforms
are expressed in each tissue or cell type, all of which have
relatively similar ligand-binding properties in vitro (Coe and
Bernlohr, 1998). In keratinocytes, we found that the expres-
sion of E-FABP was strikingly high compared with that of
A-FABP, making functional compensation by A-FABP un-
likely in E-FABP/ keratinocytes. Given our finding that
E-FABP deletion in keratinocytes does not severely impact
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fatty acid metabolism, it can be assumed that fatty acid
metabolism must be regulated to some extent by factors other
than members of the FABP family.
A growing body of evidence suggests that fatty acids are
involved in keratinocyte homeostasis. Linoleic acid defi-
ciency results in increased transepidermal water loss (Ziboh
et al., 2000). Psoriatic patients tend to have a distinctive
dietary pattern that is characterized by the consumption of
fatty foods (Zamboni et al., 1989), and psoriatic scales have
higher amounts of fatty acid derivatives, including 13(S)-
HODE than do normal skin scales (Camp et al., 1983).
Furthermore, E-FABP has been shown to be overexpressed in
psoriatic skin (Madsen et al., 1992). Therefore, it is reason-
able to speculate that the altered metabolism of fatty acids
and abnormal keratinocyte differentiation in psoriatic skin
may be related to this drastic upregulation of E-FABP
expression in psoriasis. Many saturated fatty acids are
decreased in E-FABP/ keratinocytes, consistent with a
previous report showing that E-FABP preferentially binds to
saturated fatty acids in vitro (Hanhoff et al., 2002). Saturated
fatty acids function as an energy source and as cell
membrane constituents, but they are usually too stable to
have a role in signal transduction. Instead, polyunsaturated
fatty acids contribute to signal transduction through their
derivatives. Among polyunsaturated fatty acids, we found
that linoleic acid was decreased in E-FABP/ keratinocytes,
suggesting that E-FABP binds to linoleic acid with a higher
affinity in keratinocytes. Alternatively, E-FABP/ keratino-
cytes may fail to take up sufficient quantities of linoleic acid,
particularly if keratinocytes selectively require a large amount
of linoleic acid (Chapkin et al., 1986). The mechanism
underlying decreased levels of linoleic acid in vivo remains
to be elucidated. However, our studies suggest that the
E-FABP function is involved in linoleic acid metabolism in
keratinocytes.
E-FABP deletion disrupts K1 induction through decreased
13(S)-HODE and downregulation of the NF-jB signaling
pathway
Polyunsaturated fatty acids generate monohydroxy deriva-
tives, which regulate multiple cellular functions. Arachidonic
acid generates hydroxyeicosatetraenoic acids, whereas lino-
leic acid generates 9(S)-HODE and 13(S)-HODE. We found
that E-FABP deletion results in a decrease in linoleic acid and
its derivative, 13(S)-HODE. In the epidermis, LOXs preferen-
tially metabolize linoleic acid to 13(S)-HODE (Ziboh et al.,
2000). This supports our belief that the depletion of linoleic
acid leads to decreased 13(S)-HODE. As we saw little
difference in LOX mRNA levels in E-FABPþ /þ and
E-FABP/ keratinocytes, it seems unlikely that decreased
13(S)-HODE is caused by altered LOX expression in E-FABP/
keratinocytes. Although 13(S)-HODE exerts various effects on
processes such as cell adhesion and apoptosis, it has also
been reported to antagonize K1 downregulation and hyperpro-
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Figure 6. Decreased NF-jB activity in E-FABP/ keratinocytes. (a) Activity of NF-kB and AP-1 in E-FABP/ and E-FABPþ /þ keratinocytes. (b) Immunoblot
analysis using antibodies against IkBa. (c) Measurement of NF-kB activity in E-FABP/ versus E-FABPþ /þ keratinocytes treated with various concentrations of
13(S)-HODE for 6 hours. (d) K1 expression in E-FABP/ versus E-FABPþ /þ keratinocytes treated with 13(S)-HODE for 12 hours. Tubulin-a was used as a loading
control. (e) Measurement of PPAR activity in E-FABP/ versus E-FABPþ /þ keratinocytes treated with 30 nM of HODEs for 6 hours. Values represent fold
induction relative to E-FABPþ /þ keratinocytes without treatment. (f) Measurement of PPAR activity in response to PPAR agonist treatment of E-FABP/ and
E-FABPþ /þ keratinocytes. Error bars represent SD. *Po0.05. Data are representative of three independent experiments. E-FABP, epidermal fatty acid-binding
protein; HODE, hydroxyoctadecadienoic acid; PPAR, peroxisome proliferator-activated receptor.
610 Journal of Investigative Dermatology (2011), Volume 131
E Ogawa et al.
FABP Mediates Epidermal Differentiation
liferation in keratinocytes, an effect that may be mediated
by the suppression of the protein kinase C signaling pathway
(Hagerman et al., 1997). The effects of 13(S)-HODE on K1
expression are consistent with the observation that K1 expres-
sion is suppressed in E-FABP/ keratinocytes; however, we did
not detect altered protein kinase C activity in E-FABP/
keratinocytes. Rather, we found that 13(S)-HODE enhances NF-
kB activity in keratinocytes through phosphorylation of Ik
kinase-b–IkB, leading to the induction of K1 expression.
Interestingly, the effects of 13(S)-HODE on NF-kB activation
are eliminated in E-FABP/ keratinocytes, which is consistent
with the finding that E-FABP is necessary for 13(S)-HODE-
induced K1 expression. E-FABP seems to be required not only
for the metabolism of linoleic acid and 13(S)-HODE but also for
the regulation of the NF-kB signaling pathway by 13(S)-HODE.
E-FABP depletion affects 13(S)-HODE-mediated NF-kB activa-
tion and K1 expression. E-FABP may contribute to the transport
of 13(S)-HODE as a complex, leading to NF-kB activation.
In keratinocytes, NF-kB activation inhibits cell-cycle
progression, and also prevents premature apoptosis (Seitz
et al., 2000). In contrast, NF-kB does not have a strong impact
on keratinocyte differentiation, although gene expression
profiling has shown that NF-kB induces K10 (Hinata et al.,
2003), a keratin that is induced together with K1 in the early
stages of differentiation. In our analysis, K1 expression was
induced by an NF-kB activator and suppressed by an NF-kB
inhibitor, suggesting that NF-kB promotes keratinocyte
differentiation.
Inv and Lor are induced during later stages of keratinocyte
differentiation than K1. Keratinocyte differentiation requires
precisely coordinated expression of differentiation-specific
proteins, each of which is regulated by different signaling
pathways (Dotto, 1999; Fuchs, 2008). Unlike K1, Inv and Lor
were induced independently of the NF-kB signal pathway
(data not shown) and of 13(S)-HODE stimulation. Although
the mechanism of Lor induction is still not clear, Inv
induction is dependent on signals mediated by protein kinase
C, extracellular signal-regulated kinase, and p38 (Eckert
et al., 2004). In this study, we did not detect any differences
in the activity of these signaling pathways in E-FABP/ and
E-FABPþ /þ keratinocytes. E-FABP affects the levels of Inv
and Lor expression, while the underlying mechanism of K1
induction appears to be distinct and will be an important
topic for future study.
13(S)-HODE is known to be one of the natural ligands of
PPAR (Zuo et al., 2006). In keratinocytes, PPAR inhibits
apoptosis and promotes viability and differentiation (Michalik
et al., 2001; Di-Poi et al., 2002). Tan et al. (2002) reported
that E-FABP overexpression enhanced transactivation of the
PPAR pathway, which induced keratinocyte differentiation.
However, we did not observe any changes in PPAR activity in
E-FABP/ keratinocytes. One possible explanation is that
both E-FABP-dependent and E-FABP-independent signaling
pathways exist for PPAR activation in keratinocytes and that
E-FABP-independent PPAR activity is increased in E-FABP/
keratinocytes.
It has been proposed that a close relationship exists
between fatty acid metabolism and the pathogenesis of
psoriasis (Kragballe and Fogh, 1989; Zamboni et al., 1989;
Mayser et al., 2002). Given the strong relationship between
E-FABP and fatty acids, and the increased expression of
E-FABP in psoriasis, the pathogenesis of psoriasis may be
influenced by E-FABP activity through impaired metabolism
of fatty acids and their derivatives.
MATERIALS AND METHODS
Mice and cell cultures
This study followed international ethical guidelines for the care and
use of laboratory animals and was approved by the local
International Animal Care and Use Committee. The generation of
E-FABP/mice has been described previously (Owada et al., 2002).
Primary keratinocytes were cultured as described previously
(Missero et al., 1996). To measure fatty acid incorporation,
0.1 mCiml1 of 14C linoleic acid or 14C a-linolenic acid (Amersham,
Tokyo, Japan) was added to cultured keratinocytes. Radioactivity
was measured using a b-scintillation counter. 13-HODE was
quantified as described previously (Hishinuma et al., 2008). Detailed
procedures are described in Supplementary information online.
Immunoblotting, immunohistochemistry, transfection, reporter
assay, and reverse transcription-PCR
Immunoblotting, immunohistochemistry, transfection, reporter
assay, and reverse transcriptase-PCR were performed as described
previously (Okuyama et al., 2004, 2007; Ogawa et al., 2008). PCR
primer sets and plasmid constructs used in this study are described in
Supplementary information online.
DNA microarray analysis
A comparison of GeneChip array data from E-FABPþ /þ and
E-FABP/ keratinocytes was obtained from Kurabo Custom Analysis
Services (Kurabo, Osaka, Japan). Total RNA was reverse transcribed
to generate cDNA using the T7 oligo(dT) primer. The labeled cDNA
products were hybridized onto GeneChip(R) Mouse Genome 430
A2.0 arrays (Affymetrix, Tokyo, Japan).
Determination of fatty acid content of the epidermis
Detailed procedures are described in Supplementary information
online.
Statistical analyses
Data were analyzed using Student’s t-test for unpaired observations.
Differences were considered significant at Po0.05.
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